Mild COVID-19 induces lasting antibody protection: Study
First Published: 25th May, 2021 22:20 IST
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19. Such cells could persist for
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19. Such cells could persist for a lifetime, churning out antibodies all the while, suggested a new study.
The study, led by the researchers at Washington University School of Medicine in St. Louis, was published in the journal ‘Nature’.
The findings of the study suggested that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon.
“Last fall, there were reports that antibodies wane quickly after infection with the virus that causes COVID-19, and mainstream media interpreted that to mean that immunity was not long-lived,” said senior author Ali Ellebedy, PhD, an associate professor of pathology and immunology, of medicine and of molecular microbiology.
Ellebedy added, “But that’s a misinterpretation of the data. It’s normal for antibody levels to go down after acute infection, but they don’t go down to zero; they plateau. Here, we found antibody-producing cells in people 11 months after first symptoms. These cells will live and produce antibodies for the rest of people’s lives. That’s strong evidence for long-lasting immunity.”
During a viral infection, antibody-producing immune cells rapidly multiply and circulate in the blood, driving antibody levels sky-high. Once the infection is resolved, most such cells die off, and blood antibody levels drop.
A small population of antibody-producing cells, called long-lived plasma cells, migrate to the bone marrow and settle in, where they continually secrete low levels of antibodies into the bloodstream to help guard against another encounter with the virus.
The key to figuring out whether COVID-19 leads to long-lasting antibody protection, Ellebedy realized, lies in the bone marrow. To find out whether those who have recovered from mild cases of COVID-19 harbor long-lived plasma cells that produce antibodies specifically targeted to SARS-CoV-2, the virus that causes COVID-19.
Ellebedy teamed up with co-author Iskra Pusic, MD, an associate professor of medicine. Ellebedy already was working with co-authors Rachel Presti, MD, PhD, an associate professor of medicine, and Jane O’Halloran, MD, PhD, an assistant professor of medicine, on a project to track antibody levels in blood samples from COVID-19 survivors.
The team already had enrolled 77 participants who were giving blood samples at three-month intervals starting about a month after initial infection. Most participants had mild cases of COVID-19; only six had been hospitalized.
With Pusic’s help, Ellebedy and colleagues obtained bone marrow from 18 of the participants seven or eight months after their initial infections. Five of them came back four months later and provided a second bone marrow sample. For comparison, the scientists also obtained bone marrow from 11 people who had never had COVID-19.
As expected, antibody levels in the blood of the COVID-19 participants dropped quickly in the first few months after infection and then mostly leveled off, with some antibodies detectable even 11 months after infection.
Further, 15 of the 19 bone marrow samples from people who had had COVID-19 contained antibody-producing cells specifically targeting the virus that causes COVID-19. Such cells could still be found four months later in the five people who came back to provide a second bone-marrow sample. None of the 11 people who had never had COVID-19 had such antibody-producing cells in their bone marrow.
“People with mild cases of COVID-19 clear the virus from their bodies two to three weeks after infection, so there would be no virus driving an active immune response seven or 11 months after infection,” Ellebedy said.
“These cells are not dividing. They are quiescent, just sitting in the bone marrow and secreting antibodies. They have been doing that ever since the infection resolved, and they will continue doing that indefinitely,” Ellebedy added.
People who were infected and never had symptoms also may be left with long-lasting immunity, the researchers speculated. But it’s yet to be investigated whether those who endured more severe infection would be protected against a future bout of disease, they said.
“It could go either way,” said first author Jackson Turner, PhD, an instructor in pathology and immunology.
Turner further said, “Inflammation plays a major role in severe COVID-19, and too much inflammation can lead to defective immune responses. But on the other hand, the reason why people get really sick is often because they have a lot of virus in their bodies, and having a lot of virus around can lead to a good immune response. So it’s not clear. We need to replicate the study in people with moderate to severe infections to understand whether they are likely to be protected from reinfection.”
Ellebedy and colleagues are now studying whether vaccination also induces long-lived antibody-producing cells. (ANI)
COMMENTS
TOPMOST STORY NOW
Live Union Tourism Ministry pulls up Sikkim Tourism Dept for ‘exploitative’ cab rates
18th May 2024Live Meghalaya: Retaining wall of new Assembly building collapses in Mawdiangdiang
18th May 2024Live Tripura: Poor performance of 125 Vidyajyoti Schools sparks political controversy
18th May 2024Live Illegal appointments in PHE & WS department: ACS seek termination of corrupt officials
18th May 2024WE RECOMMEND
“Swati Maliwal ka Sach”: AAP attacks Maliwal after purported clip from day of “assault” goes viral
In a post on social media platform X, AAP stated, "Swati Maliwal ka sach (Swati Maliwal's truth)." The post refers to a news story with a purported video clip of the Rajya Sabha MP and security personnel at CM Kejriwal's house on May 13. Delhi Police say that the video is yet to be authenticated by them.
17th May 2024Air India flight from Pune collides with tug truck before takeoff
Airport officials have confirmed the incident and stated that "the passengers were immediately deplaned and arrangements were made for an alternative flight to Delhi."
17th May 2024Union minister Jyotiraditya Scindia’s mother, Madhvi Raje, passes away
The Civil Aviation Minister, Jyotiraditya Scindia is seeking a fresh term in the Lok Sabha from Guna in Madhya Pradesh.
15th May 2024Flight Thief: Man boarded over 200 flights, robbed passengers mid-air of jewellery and goods worth crores
The police scanned several hours of CCTV footage from airports and arrested Rajesh Kapoor.
14th May 2024ICMR warns against sipping tea or coffee just before or after meals. Here is why
While the ICMR has not asked people to completely avoid tea or coffee, but it has cautioned consumers to beware of the caffeine content in these beverages.
14th May 2024